CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 300 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06346938
NCT06346938N/ARecruitingOn TrackUpdated 10mo ago

The Clinical Significance of CT-based Biomarkers in the Classification and Prognosis of Bronchiectasis

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology·observational·Posted Apr 4, 2024·Updated Aug 19, 2025

In Brief

An observational study for Bronchiectasis. Currently recruiting, targeting 300 participants across 1 site.

Detailed Summary

As the third major chronic airway disease in China, bronchiectasis has a wide range of patients. However, the involved sites, morphological features and airway obstruction of bronchiectasis are varied, and clinical heterogeneity is high, making prognosis and severity difficult to evaluate. CT plays an important role in the diagnosis and classification of ramadasis. Based on this, we analyzed the CT findings of patients with bronchiectasis and followed up patients with bronchiectasis to understand their disease progression and prognosis, so as to further analyze the role of CT biomarkers in the type and prognosis of bronchiectasis diseases.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiectasis
CountriesChina
Collaborators--

Timeline

N/ARecruiting
202520262027
First PostedApr 4, 2024
Enrollment StartMar 30, 2024
Primary CompletionMar 26, 2027
TodayJul 1, 2026
Enrollment to primary: 3.0 yearsPosted 2.2 years agoPrimary completion in 9 months